Our core content on Lung conditions and related factsheets has been translated to a number of other languages.
For more languages explore all available Factsheet translations.
Volunteer as a translator or learn how to translate using Chrome, Firefox or Edge browsers.
Our core content on Lung conditions and related factsheets has been translated to a number of other languages by our volunteer team.
For more languages explore all available Factsheet translations.
Volunteer as a translator or learn how to translate using Chrome, Firefox or Edge browsers.
Scientists in the USA have found that the benefits of targeted lung cancer treatments could be similar among smokers and non-smokers.
Certain types of lung cancers are driven by a change in a person’s genetic make-up, and can therefore be treated with therapies that target these genetic changes.
The research, published in the journal Clinical Cancer Research, aimed to find out whether a person’s smoking status would have an impact on the effectiveness of these targeted treatments.
The study involved 904 people with lung cancer who tested positive for a genetic factor that could be treated with a targeted therapy. It then looked at the effect of these therapies, alongside smoking status, on survival rates.
The researchers found that people receiving these targeted therapies lived an average of 1.5 years longer than people who did not – regardless of whether they smoked, used to smoke or had never smoked.
It is worth noting that cancers in smokers are less likely to be the type that can be currently treated with these targeted therapies.
Based on their findings, the researchers recommend that all people with lung cancer are tested to see if they could benefit from targeted therapies.
Read the abstract of the journal article.
Download our ‘quitting smoking – the benefits’ factsheet.
Get more information on lung cancer on the patient priorities website.
Sign up to our free monthly newsletter to get the latest information and research news on lung conditions, plus views from experts and patients! You can unsubscribe at any time.
ELF is a non-profit organisation registered as a UK company (VAT no. GB 115 0027 74) and charity (no. 1118930).
Our Brussels office enterprise number is 0738.383.695
European Lung Foundation's TR ID number in the Transparency Register is: 094039644810-79
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.
Advertisement cookies are used to provide visitors with relevant ads and marketing campaigns. These cookies track visitors across websites and collect information to provide customized ads.
No description